Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions - Wikidata - awgldk - TriplyDB

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions

http://www.wikidata.org/entity/Q36830032

about

Tenascin-C is a useful marker for disease activity in myocarditis Advances in tenascin-C biology.Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.Matricellular proteins in cardiac adaptation and disease.Comparative mRNA and MicroRNA Profiling during Acute Myocardial Infarction Induced by Coronary Occlusion and Ablation Radio-Frequency Currents.Matricellular proteins: new molecular targets to prevent heart failure.Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4

P2860

Q28214545-360DE8C3-EED1-4A0B-9EEC-905A5C740E00 Q35214557-04788DAA-48E8-430B-B1F6-7D30010D2B88 Q35365832-ECA4AF98-1045-49D1-9828-270F5A3AABBF Q35542423-0E14C522-FD81-41E1-A6E8-27BAC2DB4F55 Q37441111-5D257D29-8B23-4826-8D93-53CD0C81C369 Q37925022-13974AE9-08F8-45D2-B935-169E1D1F1632 Q38308741-551C23BF-6A1E-4A87-8670-3F9F7FB0A02C Q38594699-B8FB1013-0DFF-4A72-8CDC-E0CAA00F6756 Q40168710-CFBEAFD7-FE91-4DFC-91B6-5A0DF96349B2 Q40818988-9F9CFEAE-07A1-4E45-BDF6-A34C9FB50162 Q42767722-5D2B2646-EB67-4BDF-859C-2B39F42B72BA

P2860

Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions

http://www.wikidata.org/entity/Q36830032

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Tenascin expression in endomyo ...... ong margin of fibrotic lesions

@en

type

label

Tenascin expression in endomyo ...... ong margin of fibrotic lesions

@en

prefLabel

Tenascin expression in endomyo ...... ong margin of fibrotic lesions

@en

P1433

Q36830032-0AEC292A-B973-4DB0-82E8-1505C038572C

P1476

Q36830032-6383872B-13B6-41A7-8C84-78C8C1466328

P2093

Q36830032-10020A01-F736-4220-AE83-1A7E79D8BAFE

Q36830032-413423A9-4A23-4641-8E38-E8385BA36852

Q36830032-645D3E4F-7DDA-4BFB-B221-D60A8293C05E

Q36830032-66ED1C13-62C1-443C-BDEA-D3CFAAF81087

Q36830032-89FBF579-5FC7-4759-BE12-182416F34A4A

Q36830032-CA753AB9-CFBB-4328-BA67-081FA6B72833

Q36830032-EB3BB036-4BCA-47AD-8FB6-F17D9954500D

P2860

Q36830032-01585CBF-7DA6-423A-BA98-4E78F63A8841

Q36830032-090548F7-B571-41EC-BB39-5FD11E6174B5

Q36830032-187CE94A-B67F-417E-B127-FBC9F4934DCA

Q36830032-4793C08E-FF86-4A12-A5BB-F5ED2D05C410

Q36830032-6DC4D8A5-C04E-4DE6-83AD-45B6C8B3BB1D

Q36830032-8622F887-C15F-4E8A-B81A-821C2C76CEF6

Q36830032-98BE2597-43DD-487C-8741-11C6B7B3B1E1

Q36830032-9F9220C5-EB29-4044-B681-FD18FAF1F767

Q36830032-A300B6AB-90F7-4CD2-81C2-77D9E91AAFF9

Q36830032-B03E230A-417A-42FA-92F6-7C64C2E31840

P304

Q36830032-AA946927-1B54-4116-BF7C-BF5C36773FAC

P31

Q36830032-B453B43A-D35D-439C-BA3D-E8841DF0721E

P356

Q36830032-078CAEFF-9476-4EE2-BAF8-6E0DB6B0551D

P407

Q36830032-BE6D6DB4-1693-43C5-BEF8-562B6BB2406E

P433

Q36830032-28526315-D412-4273-86E1-35BD30BA63D2

P478

Q36830032-51356275-CC8C-4195-B063-564677C9E9E3

P577

Q36830032-1BE13E0D-B5F8-4DF5-9FF3-D40B2265A6E5

P5875

Q36830032-A87D2591-82F2-4980-89F0-9D3ED48C6E43

P698

Q36830032-D92DD5C8-7A42-4D7E-975F-FA926953D30F

P932

Q36830032-17C8DA43-C18F-417A-BB57-30A00E3694FE

P356

P1433

P1476

Tenascin expression in endomyo ...... ong margin of fibrotic lesions

@en

P2093

Hirohata S

http://www.w3.org/2001/XMLSchema#string

Kajikawa Y

http://www.w3.org/2001/XMLSchema#string

Kusachi S

http://www.w3.org/2001/XMLSchema#string

Nogami K

http://www.w3.org/2001/XMLSchema#string

Tamura A

http://www.w3.org/2001/XMLSchema#string

Tsuji T

http://www.w3.org/2001/XMLSchema#string

Yamanishi A

http://www.w3.org/2001/XMLSchema#string

P2860

An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis

Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro

Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme

Induction of tenascin in healing wounds.

Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme.

Isolation and characterization of human fibroblast tenascin. An extracellular matrix glycoprotein of interest for developmental studies.

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis.

P304

291-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.75.3.291

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14402295

http://www.w3.org/2001/XMLSchema#string

P698

8800995

http://www.w3.org/2001/XMLSchema#string

P932

484289

http://www.w3.org/2001/XMLSchema#string